Vaccinex, Inc. (VCNX)

NASDAQ: VCNX · IEX Real-Time Price · USD
7.41
-0.09 (-1.20%)
At close: Mar 28, 2024, 3:44 PM
8.29
+0.88 (11.88%)
After-hours: Mar 28, 2024, 7:50 PM EDT

Total Valuation

Vaccinex has a market cap or net worth of $8.69 million. The enterprise value is $8.87 million.

Market Cap 8.69M
Enterprise Value 8.87M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, after market close.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

Vaccinex has 1.17 million shares outstanding. The number of shares has increased by 58.45% in one year.

Shares Outstanding 1.17M
Shares Change (YoY) +58.45%
Shares Change (QoQ) +11.89%
Owned by Insiders (%) 9.18%
Owned by Institutions (%) 56.64%
Float 326,297

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.93
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 11.16
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.35

Current Ratio 0.35
Quick Ratio 0.17
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -2,667.30%.

Return on Equity (ROE) -2,667.30%
Return on Assets (ROA) -475.50%
Return on Capital (ROIC) n/a
Revenue Per Employee $20,921
Profits Per Employee -$579,263
Employee Count 38
Asset Turnover 0.17
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -90.84% in the last 52 weeks. The beta is 0.76, so Vaccinex's price volatility has been lower than the market average.

Beta (1Y) 0.76
52-Week Price Change -90.84%
50-Day Moving Average 8.58
200-Day Moving Average 27.59
Relative Strength Index (RSI) 38.76
Average Volume (30 Days) 11,528

Short Selling Information

The latest short interest is 8,792, so 0.75% of the outstanding shares have been sold short.

Short Interest 8,792
Short Previous Month 14,828
Short % of Shares Out 0.75%
Short % of Float 2.69%
Short Ratio (days to cover) 0.44

Income Statement

In the last 12 months, Vaccinex had revenue of $795,000 and -$22.01 million in losses. Loss per share was -$84.56.

Revenue 795,000
Gross Profit 795,000
Operating Income -23.02M
Pretax Income -22.01M
Net Income -22.01M
EBITDA -21.88M
EBIT -22.01M
Loss Per Share -$84.56
Full Income Statement

Balance Sheet

The company has $127,000 in cash and $307,000 in debt, giving a net cash position of -$180,000 or -$0.15 per share.

Cash & Cash Equivalents 127,000
Total Debt 307,000
Net Cash -180,000
Net Cash Per Share -$0.15
Equity / Book Value -3.87M
Book Value Per Share -3.32
Working Capital -4.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.24 million and capital expenditures -$65,000, giving a free cash flow of -$18.31 million.

Operating Cash Flow -18.24M
Capital Expenditures -65,000
Free Cash Flow -18.31M
FCF Per Share -$56.87
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -2,895.09% and -2,768.81%.

Gross Margin 100.00%
Operating Margin -2,895.09%
Pretax Margin -2,768.81%
Profit Margin -2,768.81%
EBITDA Margin -2,751.57%
EBIT Margin -2,768.81%
FCF Margin -2,302.64%

Dividends & Yields

Vaccinex does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -58.45%
Shareholder Yield -58.45%
Earnings Yield -253.26%
FCF Yield -210.62%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on February 20, 2024. It was a reverse split with a ratio of 1:14.

Last Split Date Feb 20, 2024
Split Type Reverse
Split Ratio 1:14

Scores

Vaccinex has an Altman Z-Score of -213.45 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -213.45
Piotroski F-Score 3